These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3661548)

  • 1. Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis.
    Shah GM; Winer RL; Cutler RE; Arieff AI; Goodman WG; Lacher JW; Schoenfeld PY; Coburn JW; Horowitz AM
    Am J Kidney Dis; 1987 Oct; 10(4):268-75. PubMed ID: 3661548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of magnesium hydroxide and low magnesium dialysate does not permit reduction of aluminum hydroxide during continuous ambulatory peritoneal dialysis.
    Jennings AE; Bodvarsson M; Galicka-Piskorska G; Diefendorf AS; Simon GM; Levey AS
    Am J Kidney Dis; 1986 Sep; 8(3):192-5. PubMed ID: 3752074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
    Weinreich T; Passlick-Deetjen J; Ritz E
    Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis.
    Guillot AP; Hood VL; Runge CF; Gennari FJ
    Nephron; 1982; 30(2):114-7. PubMed ID: 7099318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sevelamer hydrochloride versus aluminum hydroxide: effect on serum phosphorus and lipids in CAPD patients.
    Katopodis KP; Andrikos EK; Gouva CD; Bairaktari ET; Nikolopoulos PM; Takouli LK; Tzallas CS; Elisaf MS; Pappas MV; Siamopoulos KC
    Perit Dial Int; 2006; 26(3):320-7. PubMed ID: 16722024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.
    Katopodis KP; Koliousi EL; Andrikos EK; Pappas MV; Elisaf MS; Siamopoulos KC
    Artif Organs; 2003 Sep; 27(9):853-7. PubMed ID: 12940910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations.
    Hutchison AJ; Were AJ; Boulton HF; Mawer EB; Laing I; Gokal R
    Nephron; 1996; 72(1):52-8. PubMed ID: 8903861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients.
    Takahashi S; Okada K; Yanai M
    Perit Dial Int; 1994; 14(1):75-8. PubMed ID: 8312420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
    Honkanen E; Kala AR; Grönhagen-Riska C; Ikäheimo R
    Adv Perit Dial; 1992; 8():356-61. PubMed ID: 1361822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis.
    Delmez JA; Slatopolsky E; Martin KJ; Gearing BN; Harter HR
    Kidney Int; 1982 Jun; 21(6):862-7. PubMed ID: 6897087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid.
    Hutchison AJ; Merchant M; Boulton HF; Hinchcliffe R; Gokal R
    Perit Dial Int; 1993; 13(3):219-23. PubMed ID: 8369353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis.
    Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F
    Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders.
    Parsons V; Baldwin D; Moniz C; Marsden J; Ball E; Rifkin I
    Nephron; 1993; 63(4):379-83. PubMed ID: 8459870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of serum ionized magnesium in CAPD patients.
    Saha HH; Harmoinen AP; Pasternack AI
    Perit Dial Int; 1997; 17(4):347-52. PubMed ID: 9284461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S; Brandi L; Olgaard K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E; Bernardini J; Holley J; Chen T; Piraino B
    Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol/L calcium in peritoneal dialysis patients.
    Bender FH; Bernardini J; Piraino B
    Am J Kidney Dis; 1992 Oct; 20(4):367-71. PubMed ID: 1415205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.